Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro). It joins the ACTH(4-7) fragment to a Pro-Gly-Pro tail added for stability, and was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s. Published research, most of it in Russian, includes animal studies of gene expression in models of reduced blood flow to the brain.
Technical details
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP) |
|---|---|
| Formula | C37H51N9O10S |
| Molecular weight | 813.9 g/mol |
| CAS | 80714-61-0 |
| PubChem CID | 9811102 |
| Form | Freeze-dried powder, 30 mg per vial |
| Research to date | Mostly animal studies; most published work is in Russian |
Lab certificate
A third-party certificate of analysis for the current batch will be posted on this page once testing is complete.
Storage
Store the sealed vial in a freezer at around -20 °C, away from light and moisture.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes.
